Levosimendan: The current situation and new prospects

Rev Port Cardiol. 2014 Dec;33(12):795-800. doi: 10.1016/j.repc.2014.05.009. Epub 2014 Nov 14.

Abstract

Levosimendan is a pyridazinone-dinitrile derivative with positive inotropic and vasodilatory effects that has beneficial effects on myocardial performance. In previous randomized studies levosimendan improved hemodynamics and clinical course, but its effect on prognosis is still unclear. This important issue has limited its use. Although primarily used in the management of acute heart failure syndromes, this new inotropic agent may play a role in other clinical conditions. This review aims to summarize current knowledge on levosimendan and to present future prospects for the use of this drug.

Keywords: Heart failure; Inotropes; Inotrópicos; Insuficiência cardíaca; Levosimendan.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiotonic Agents / therapeutic use*
  • Heart Failure / drug therapy
  • Humans
  • Hydrazones / therapeutic use*
  • Pyridazines / therapeutic use*
  • Simendan

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan